Michael Egholm
Chief Executive Officer presso STANDARD BIOTOOLS INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Troy Cox | M | 60 | 3 anni | |
| Eli Casdin | M | 51 | 3 anni | |
| Thomas Carey | M | 62 | 1 anni | |
| Kathy Hibbs | F | 60 | 1 anni | |
| Adam Taich | M | 49 | 3 anni | |
| Hanjoon Kim | M | 53 | 6 anni | |
| Michael P. Weiner | M | - |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | 4 anni |
| A. Sanders | M | 61 | 3 anni | |
| Jessica Mega | M | 49 | 5 anni | |
| Fenel Eloi | M | 66 | 1 anni | |
| Frank R. Witney Witney | M | 70 | 2 anni | |
| Raymond Stevens | M | 60 | 7 anni | |
| Jeffrey Black | M | 55 | 1 anni | |
| Alex de Winter | M | - | 4 anni | |
| Katherine J. Flagg | F | - | - | |
| John H. Leamon | M | - | 3 anni | |
| Sean Mackay | M | 41 |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | - |
| Pardis Sabeti | M | 48 | 5 anni | |
| Anthony Catalano | M | - | 3 anni | |
| John Bedford | M | - | 3 anni | |
| Elizabeth Jensen | F | 50 | 1 anni | |
| Shane Bowen | M | - | - | |
| John Kelly Sweeney | M | 54 | 7 anni | |
| Manny Resendes | M | - | 3 anni | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 3 anni | |
| Jeremy Davis | M | - | 2 anni | |
| Linda Stevens | F | - |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael Egholm
- Contatti personali
